A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $15 to $42

Moomoo News08:00 ET · Ratings

Rocket Pharmaceuticals Price Target Lowered to $15 From $29 at Goldman Sachs

TipRanks19:55 ET

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks 12:30 ET

Morgan Stanley Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TipRanksFeb 28 09:08 ET · Ratings

A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $32 to $42

Moomoo NewsFeb 28 08:00 ET · Ratings

Rocket Pharmaceuticals Is Maintained at Buy by Needham

Dow JonesFeb 28 07:36 ET · Ratings

Rocket Pharmaceuticals Analyst Ratings

BenzingaFeb 28 07:24 ET · Ratings

Promising Pipeline and Market Opportunities Drive Buy Rating for Rocket Pharmaceuticals

TipRanksFeb 28 06:27 ET

Express News | Rocket Pharmaceuticals Inc : Needham Cuts Target Price to $42 From $52

ReutersFeb 28 06:16 ET

Rocket Pharmaceuticals Executive Makes Significant Stock Sale

TipRanksFeb 27 21:05 ET

Analysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Janux Therapeutics Inc (JANX)

TipRanksFeb 27 20:40 ET · Ratings

8-K: Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

SECFeb 27 16:48 ET · Announcements

Rocket Pharmaceuticals Q4 2024 GAAP EPS $(0.62) Beats $(0.71) Estimate

BenzingaFeb 27 16:34 ET

Express News | Rocket Pharmaceuticals: Expects Cash Resources Sufficient to Fund Operations Into Q3 2026

ReutersFeb 27 16:27 ET

10-K: FY2024 Annual Report

SECFeb 27 16:02 ET · Announcements

Express News | Rocket Pharmaceuticals Q4 Basic EPS USD -0.62

ReutersFeb 27 16:01 ET

Press Release: Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

Dow JonesFeb 27 16:01 ET

Insiders Could Have Profited By Holding Onto Rocket Pharmaceuticals Shares Despite 13% Drop

Simply Wall StFeb 26 08:24 ET

Rocket Pharmaceuticals Executives Cash Out: See Who Sold Big!

TipRanksFeb 25 21:03 ET

Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner

Zacks Jan 15 08:40 ET